홈STAR • NSE
add
Strides Pharma Science Ltd
전일 종가
₹618.10
일일 변동폭
₹605.85 - ₹631.95
52주 변동폭
₹309.02 - ₹804.00
시가총액
579.15억 INR
평균 거래량
61.05만
주가수익률
24.99
배당수익률
0.40%
기본 거래소
NSE
시장 뉴스
재무
손익계산서
수익
순이익
(INR) | 2024년 9월info | 전년대비 변동 |
---|---|---|
수익 | 120.11억 | 20.18% |
운영비 | 51.79억 | 6.06% |
순이익 | 9.32억 | 170.98% |
순이익률 | 7.76 | 159.06% |
주당 수익 | — | — |
EBITDA | 23.48억 | 53.62% |
유효 세율 | 18.46% | — |
대차대조표
총자산
총부채
(INR) | 2024년 9월info | 전년대비 변동 |
---|---|---|
현금 및 단기 투자 | 24.70억 | -24.31% |
총자산 | 598.96억 | -5.49% |
총부채 | 377.46억 | -13.11% |
총자기자본 | 221.50억 | — |
발행 주식 | 9194.48만 | — |
주가순자산비율 | 2.50 | — |
총자산이익률 | — | — |
자본이익률 | 10.17% | — |
현금 흐름
순현금흐름
(INR) | 2024년 9월info | 전년대비 변동 |
---|---|---|
순이익 | 9.32억 | 170.98% |
영업 현금 흐름 | — | — |
투자 현금 흐름 | — | — |
자금 조달 현금 흐름 | — | — |
순현금흐름 | — | — |
잉여 현금 흐름 | — | — |
정보
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India.
Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab. In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies.
Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception. Wikipedia
설립
1990
웹사이트
직원 수
3,065